# Efficacy of SNX-1012 in the Treatment of Oral Mucositis

> **NCT00385515** · PHASE2 · COMPLETED · sponsor: **Mucosal Therapeutics** · enrollment: 81 (actual)

## Conditions studied

- Stomatitis
- Oral Mucositis

## Interventions

- **DRUG:** SNX-1012 (meclocycline sulfosalicylate)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00385515
- **Lead sponsor:** Mucosal Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-05
- **Final completion:** 2008-07
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2009-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385515, "Efficacy of SNX-1012 in the Treatment of Oral Mucositis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00385515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*